These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8954825)

  • 41. A CD and an NMR study of multiple bradykinin conformations in aqueous trifluoroethanol solutions.
    Cann JR; Liu X; Stewart JM; Gera L; Kotovych G
    Biopolymers; 1994 Jul; 34(7):869-78. PubMed ID: 8054469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products.
    Sheikh IA; Kaplan AP
    Biochem Pharmacol; 1989 Mar; 38(6):993-1000. PubMed ID: 2539165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins.
    Santos EL; de Picoli Souza K; Cibrián-Uhalte E; Oliveira SM; Bader M; Costa-Neto CM; Oliveira L; Pesquero JB
    Int Immunopharmacol; 2008 Feb; 8(2):282-8. PubMed ID: 18182241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Agonist activity at the kinin B1 receptor: structural requirements of the central tetrapeptide.
    Rovero P; Pellegrini M; Di Fenza A; Meini S; Quartara L; Maggi CA; Formaggio F; Toniolo C; Mierke DF
    J Med Chem; 2001 Jan; 44(2):274-8. PubMed ID: 11170638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular kinin B(1) and B(2) receptor-mediated effects in the rat isolated perfused kidney - differential regulations.
    Bagaté K; Develioglu L; Imbs JL; Michel B; Helwig JJ; Barthelmebs M
    Br J Pharmacol; 1999 Dec; 128(8):1643-50. PubMed ID: 10588918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utilization of a radioimmunoassay to detect the generation of Arg-Pro-Pro-Gly-Phe, a stable endproduct of bradykinin metabolism (from cultured rat aortic smooth muscle cells exposed to bradykinin).
    Morinelli TA; Meier GP; Webb JG; Jaffa AA; Privitera PJ; Margolius HS
    Int Immunopharmacol; 2002 Dec; 2(13-14):1995-2003. PubMed ID: 12489813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Degradation of bradykinin and its metabolites by rat brain synaptic membranes.
    Orawski AT; Simmons WH
    Peptides; 1989; 10(5):1063-73. PubMed ID: 2608554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat.
    Décarie A; Raymond P; Gervais N; Couture R; Adam A
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1340-7. PubMed ID: 8897926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successive cleavage of N-terminal Arg1--Pro2 and Lys3-Pro4 from substance P but no release of Arg1-Pro2 from bradykinin, by X-Pro dipeptidyl-aminopeptidase.
    Kato T; Nagatsu T; Fukasawa K; Harada M; Nagatsu I; Sakakibara S
    Biochim Biophys Acta; 1978 Aug; 525(2):417-22. PubMed ID: 687639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies of the digestion of bradykinin, lysyl bradykinin, and kinin-degradation products by carboxypeptidases A, B, and N.
    Sheikh IA; Kaplan AP
    Biochem Pharmacol; 1986 Jun; 35(12):1957-63. PubMed ID: 3718539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Purification and properties of membrane-bound aminopeptidase P from rat lung.
    Orawski AT; Simmons WH
    Biochemistry; 1995 Sep; 34(35):11227-36. PubMed ID: 7669781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclooxygenase inhibitors attenuate bradykinin-induced vasoconstriction in septic isolated rat lungs.
    Fischer LG; Hollmann MW; Horstman DJ; Rich GF
    Anesth Analg; 2000 Mar; 90(3):625-31. PubMed ID: 10702448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potentiation of the vascular response to kinins by inhibition of myocardial kininases.
    Dendorfer A; Wolfrum S; Schäfer U; Stewart JM; Inamura N; Dominiak P
    Hypertension; 2000 Jan; 35(1 Pt 1):32-7. PubMed ID: 10642271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed.
    Dumoulin MJ; Adam A; Rouleau JL; Lamontagne D
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):359-66. PubMed ID: 11300648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bradykinin metabolism in the postinfarcted rat heart: role of ACE and neutral endopeptidase 24.11.
    Raut R; Rouleau JL; Blais C; Gosselin H; Molinaro G; Sirois MG; Lepage Y; Crine P; Adam A
    Am J Physiol; 1999 May; 276(5):H1769-79. PubMed ID: 10330262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of cathepsin B involved in enkephalin production by bradykinin and its cleavage products in cultured fibroblasts of the rat dental pulp.
    Zhu BF; Kudo T; Maeda S; Inoki R
    J Osaka Univ Dent Sch; 1992 Dec; 32():27-44. PubMed ID: 1341708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
    Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulatory effect of endopeptidase inhibitors on bradykinin-induced contraction of rat uterus.
    Schriefer JA; Molineaux CJ
    J Pharmacol Exp Ther; 1993 Aug; 266(2):700-6. PubMed ID: 8394914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.